TY - JOUR
T1 - From SGAP-Model to SGAP-Score: A Simplified Predictive Tool for Post-Surgical Recurrence of Pheochromocytoma
AU - Parasiliti-Caprino, M
AU - Bioletto, F
AU - Lopez, C
AU - Bollati, M
AU - Maletta, F
AU - CAPUTO, Marina
AU - Gasco, V
AU - La, Grotta A
AU - Limone, P
AU - Borretta, G
AU - Volante, M
AU - Papotti, M
AU - Pia, A
AU - Terzolo, M
AU - Morino, M
AU - Pasini, B
AU - Veglio, F
AU - Ghigo, E
AU - Arvat, E
AU - Maccario, M
PY - 2022
Y1 - 2022
N2 - A reliable prediction of the recurrence risk of pheochromocytoma after radical surgery
would be a key element for the tailoring/personalization of post-surgical follow-up. Recently,
our group developed a multivariable continuous model that quantifies this risk based on genetic,
histopathological, and clinical data. The aim of the present study was to simplify this tool to a discrete
score for easier clinical use. Data from our previous study were retrieved, which encompassed
177 radically operated pheochromocytoma patients; supervised regression and machine-learning
techniques were used for score development. After Cox regression, the variables independently
associated with recurrence were tumor size, positive genetic testing, age, and PASS. In order to
derive a simpler scoring system, continuous variables were dichotomized, using > 50 mm for tumor
size, ≤ 35 years for age, and ≥ 3 for PASS as cut-points. A novel prognostic score was created on
an 8-point scale by assigning 1 point for tumor size > 50 mm, 3 points for positive genetic testing,
1 point for age ≤ 35 years, and 3 points for PASS ≥ 3; its predictive performance, as assessed using
Somers’ D, was equal to 0.577 and was significantly higher than the performance of any of the four
dichotomized predictors alone. In conclusion, this simple scoring system may be of value as an
easy-to-use tool to stratify recurrence risk and tailor post-surgical follow-up in radically operated
pheochromocytoma patients
AB - A reliable prediction of the recurrence risk of pheochromocytoma after radical surgery
would be a key element for the tailoring/personalization of post-surgical follow-up. Recently,
our group developed a multivariable continuous model that quantifies this risk based on genetic,
histopathological, and clinical data. The aim of the present study was to simplify this tool to a discrete
score for easier clinical use. Data from our previous study were retrieved, which encompassed
177 radically operated pheochromocytoma patients; supervised regression and machine-learning
techniques were used for score development. After Cox regression, the variables independently
associated with recurrence were tumor size, positive genetic testing, age, and PASS. In order to
derive a simpler scoring system, continuous variables were dichotomized, using > 50 mm for tumor
size, ≤ 35 years for age, and ≥ 3 for PASS as cut-points. A novel prognostic score was created on
an 8-point scale by assigning 1 point for tumor size > 50 mm, 3 points for positive genetic testing,
1 point for age ≤ 35 years, and 3 points for PASS ≥ 3; its predictive performance, as assessed using
Somers’ D, was equal to 0.577 and was significantly higher than the performance of any of the four
dichotomized predictors alone. In conclusion, this simple scoring system may be of value as an
easy-to-use tool to stratify recurrence risk and tailor post-surgical follow-up in radically operated
pheochromocytoma patients
KW - pheochromocytoma
KW - chromaffin system
KW - predictive score
KW - recurrence prediction
KW - machine learning
KW - pheochromocytoma
KW - chromaffin system
KW - predictive score
KW - recurrence prediction
KW - machine learning
UR - https://iris.uniupo.it/handle/11579/169004
M3 - Article
SN - 2227-9059
JO - Biomedicines
JF - Biomedicines
ER -